Peptides and Hormesis

References

• Ahmed, M.S., Cemerikic, B., and Agbas, A. (1992). Proper- ties and functions of human placental opioid system. Life Sci., 50:83–97.
   PubMed Web of Science ®Google Scholar
• Albini, A. and Adelmann-Grill, B.C. (1985). Collagenolytic cleav- age products of collagen type I as chemoattractants for human dermal fibroblasts. Eur. J. Cell Biol., 36:104–107.
   PubMed Web of Science ®Google Scholar
• Anderson, L.L., Ford, J.J., Klint, J., Molina, J.R., Vale, W.W., and Rivier, J. (1991). Growth hormone and prolactin secretion in hypophysial stalk-transected pigs as affected by growth hormone and prolactin-releas- ing and inhibiting factors. Proc. Soc. Exp. Biol. Med., 196:194–202.
   PubMed Web of Science ®Google Scholar
• Ando, Y., Breyer, M. D., and Jacobson, H. R. (1989). Dose- dependent heterogenous actions of vasopressin in rab- bit cortical collecting ducts. Am. J. Physiol., 256:F556– F562.
   Google Scholar
• Anggard, E.E., Botting, R.M., and Vane, J.R. (1990). Endothelins. Blood Vessels, 27:269–281.
   PubMedGoogle Scholar
• Aoshiba, K., Nagai, A., Ishihara, Y., Kagawa, J., and Takizawa, T. (1993). Effects of a1–proteinase inhibi- tor on chemotaxis and chemokinesis of polymorpho- nuclear leukocytes: its possible role in regulating poly- morphonuclear leukocyte recruitment in human subjects. J. Lab. Clin. Med., 122:333–340.
   PubMed Web of Science ®Google Scholar
• Bateson, E.A.J., Schulz, R., and Olley, P.M. (1999). Re- sponse of fetal rabbit ductus arteriosus to bradykinin: role of nitric oxide, prostaglandins, and bradykinin receptors. Ped. Res., 45:568–574.
   PubMed Web of Science ®Google Scholar
• Battegay, E.J., Raines, E.W., Seifert, R.A., Bowen-Pope, D.F., and Ross, R. (1990). TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell, 63:515–524.
   PubMed Web of Science ®Google Scholar
• Battistini, B., D’Orleans-Juste, P., and Sirois, P. (1993). Endothelins: circulating plasma levels and presence in other biologic fluids. Lab Invest., 68:600–628.
   PubMed Web of Science ®Google Scholar
• Behbehani, M.M. (1992). Physiological mechanisms of the analgesic effects of neurotensin. Ann. NY Acad. Sci., 668:253–265.
   PubMed Web of Science ®Google Scholar
• Beitz, A.J. (1982). The sites of origin of brainstem neurotensin and serotonnin projections to the rodent nucleus raphe magnus. J. Neurosci., 2:829–842.
   PubMed Web of Science ®Google Scholar
• Bellavite, P., Carletto, A., Biasi, D., Caramaschi, P., Poli, F., Suttora, F., and Bambara, L.M. (1994). Studies of skin-window exudate human neutrophils: complex patterns of adherence to serum-coated surfaces in dependence on FMLP doses. Inflammation, 18:575– 586.
   Web of Science ®Google Scholar
• Bellavite, P., Chirumbolo, S., Lippi, G., Andrioli, G., Bonazzi, L., and Ferro, I. (1993). Dual effects of formylpeptides on the adhesion of endotoxin-primed human neutro- phils. Cell Biochem. Funct., 11:231–239.
   PubMed Web of Science ®Google Scholar
• Bentel, J.M., Lebwohl, D.E., Cullen, K.J., Rubin, M.S., Rosen, N., Mendelsohn, J., and Miller W.H., Jr. (1995). Insu- lin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells. J. Cell. Physiol., 165:212–221.
   PubMed Web of Science ®Google Scholar
• Berns, M.M.J.J., Schuurmans, A.L.G., Bolt, J., Lamb, D.J., Foekens, J.A., and Mulder, E (1990). Antiproliferation effects of suramin on androgen responsive tumor cells. Eur. J. Cancer, 26:470–474.
   PubMed Web of Science ®Google Scholar
• Bianchi, B.R., Miller, T.R., Witte, D.G., and Lin, C.W. (1994). Novel CCK analogues and bombesin: A de- tailed analysis between phosphoinositide breakdown and high-dose inhibition of pancreatic enzyme secre- tion in three rodent species. J. Pharmacol. Exper. Toxicol., 268:996–1002.
   Google Scholar
• Birnbaumer, M. (1995). Mutations and diseases of G protein coupled receptors. J. Recept. Signal Transduction Res., 15:131–160.
   PubMed Web of Science ®Google Scholar
• Bookstaff, R.C., Moore, R.C., Ingall, G.B., and Peterson, R.E. (1990). Androgenic deficiency in male rats treated with perfluorodecanoic acid. Toxicol. Appl. Pharmacol., 104:322–333.
   PubMed Web of Science ®Google Scholar
• Boujrad, N., Vidic, B., Gazouli, M., Culty, M., and Papadopoulos, V. (2000). The peroxisome proliferator perfluorodecanoic acid inhibits the peripheral-type benzodiazepine receptor (PBR) expression and hor- mone-stimulated mitochondria cholesterol transport and steroid formation in Leydig cells. Endocrinology, 141:3137–3138.
   PubMed Web of Science ®Google Scholar
• Bowen-Pope, D.F. and Ross, R. (1982). Platelet-derived growth factor. II. Specific binding to cultured cells. J. Biol. Chem., 257:5161–5171.
   PubMed Web of Science ®Google Scholar
• Braden, T.D. and Conn, P.M. (1993). GnRH and its mecha- nism of action. In: Molecular Basis of Reproductive Endocrinology (P.C.K. Leung, A.J.W. Hsueh, and H.G. Friesen, Eds.) Springer-Verlag, NY, pp. 12–38. Braissant, O., Foufell, F., Scotto, C., Dauca, M., and Wahli, W. (1996). Differenntial expression of peroxisome proliferator-activiated receptors (PPARs): tissue dis- tribution of PPAR-,β, and  in the adult rat. Endocri- nology, 137:354–366.
   Google Scholar
• Broekmans, F.J., Bernardus, R.E., Broeders, A., Berkhout, G., and Schoemaker, J. (1993). Pituitary responsive- ness after administration of a GnRH agonist depot formulation: Decapeptyl CR. Clin. Endocrinol. 38:579–587.
   PubMed Web of Science ®Google Scholar
• Brown, S.L. and van Epps, D.E. (1985). Suppression of T lymphocyte chemotactic factor production by the opioid peptides β-endorphin and met-enkephalin. J. Immunol., 134:3384–3390.
   PubMed Web of Science ®Google Scholar
• Burg, M.B. and Orloff, J. (1968). Control of fluid absorption in the renal proximal tubule. J. Clin. Invest., 47:2016– 2024.
   Google Scholar
• Calabrese, E.J. and Baldwin, L.A. (2001). Scientific Founda- tions of Hormesis. Crit. Rev. Toxicol., 31:471–624.
   PubMed Web of Science ®Google Scholar
• Calabrese, E.J. and Baldwin, L.A. (2001a). The frequency of U-shaped dose-responses in the toxicological litera- ture. Toxicol. Sci., 62:330–338.
   PubMed Web of Science ®Google Scholar
• Castano, J.P., Torronteras, R., Ramirez, J.L., Gribouval, A., Sanchez-Hormingo, A., Ruiz-Navarro, A., and Gracia-Navarro, F. (1996). Somatostatin increases growth hormone (GH) secretion in a subpopula- tion of porcine somatotropes: Evidence for func- tional and morphological heterogeneity among porcine GH-producing cells. Endocrinology, 137:129–136.
   PubMed Web of Science ®Google Scholar
• Cemerikic, B., Cheng, J., Agbas, A., and Ahmed, M.S. (1991). Opioids regulate the release of human chorionic gona- dotropin hormone from trophoblast tissue. Life Sci., 49:813–824.
   PubMed Web of Science ®Google Scholar
• Cemerikic, B., Schabbing, R., and Ahmed, M.S. (1992). Selectivity and potency of opioid peptides in regulat- ing human chorionic gonadotropin release from term trophoblast tissue. Peptides, 13:897–903.
   PubMed Web of Science ®Google Scholar
• Cemerikic, B., Zamah, R., and Ahmed, M.S. (1994). Opioids regulation of human chorionic gonadotropin release from trophoblast tissue is mediated by gonadotropin releasing hormone. J. Pharmacol. Exper. Therap., 268:971–977.
   PubMed Web of Science ®Google Scholar
• Cemerikic, B., Zamah, R., and Ahmed, M.S. (1995). Opioid tolerance in human placenta due to in vitro methadone administration. J. Pharmacol. Exper. Therap., 273:987–994.
   PubMed Web of Science ®Google Scholar
• Chen, M.C., Lee, A.T., and Soll, A.H. (1991). Mitogenic response of canine fundic epithelial cells in short-term culture to transforming growth factor alpha and insu- lin-like growth factor I. J. Clin. Invest., 87:1716– 1723.
   Web of Science ®Google Scholar
• Chiu, A.T., McAll, D.E., Nguyen, T.T., Carini, D.J., Duncan, J.V., Herblin, W.F., Uyeda, R.T., Wong, P.C., Wexler,
   Google Scholar
• R.R., Johnson, A.L., and Timmermans, P.B. (1989). Discrimination of angiotensin II receptor subtypes by dithiothreitol. Eur. J. Pharmacol., 170:117–118.
   PubMed Web of Science ®Google Scholar
• Clayton, R.N. and Catt, K.J. (1981). Gonadotropin-releasing hormone receptors: Characterization, physiological regulation, and relationship to reproductive function. Endocrinol. Rev., 2:186–209.
   PubMed Web of Science ®Google Scholar
• Clayton, R.N., Solano, A.R., Garcia-Vela, A., Dufau, M.L., and Catt, K.J. (1980). Regulation of pituitary recep- tors for gonadotropin-releasing hormone during the rat estrous cycle. Endocrinology, 107:699–706.
   PubMed Web of Science ®Google Scholar
• Clineschmidt, B.V., McGuffin, J.C., and Bunting, P.B. (1979). Neurotensin: Antinociceptive action in rodents. Eur. J. Pharmacol., 54: 129–139.
   PubMed Web of Science ®Google Scholar
• Corbet, A.J. (1998). Medical manipulation of the ductus arteriosus. In: The Science and Practice of Pediatric Cardiology, 2nd ed., Vol II. (Garson, A., Jr., Bricker, J.T., Fisher, D.J., and Neish, S.R., Eds.). Williams & Wilkins, Baltimore, pp. 2497–2503.
   Google Scholar
• Cordeiro, M.F., Bhattacharya, S.S., Schultz, G.S., and Khaw, P.T. (2000). TGF-β1, -β2, and β3 in vitro: biphasic effects on Tenon’s fibroblast contraction, prolifera- tion, and migration. Invest. Ophthalmol. Visual Sci., 41:756–763.
   PubMed Web of Science ®Google Scholar
• Dasgupta, P., Singh, A.T., and Mukherjee, R. (2000). Lipophilization of somatostatin analog RC-160 with long chain fatty acid improves its antiproliferative activity on human oral carcinoma cells in vitro. Life Sci., 66(17):1557–1570.
   PubMed Web of Science ®Google Scholar
• Davidson, J.S., Flanagan, C.A., Becker, I.I., Illing, N., Sealfon, S.C., and Millar, R.P. (1994). Molecular function of the gonadotropin-releasing hormone receptor: insights from site-directed mutagenesis. Mol. Cell Endocrinol. 100:9–14.
   PubMed Web of Science ®Google Scholar
• Davies, N.T., Munday, K.A., and Parsons, B.J. (1970). The effect of angiotensin on rat intestinal fluid transfer. J. Endocrinol., 48:39–46.
   PubMed Web of Science ®Google Scholar
• De Klippel, N., Sarre, S., Ebinger, G., and Micotte, Y. (1993). Effect of M1 and M2 muscarinic drugs on striatal dopamine release and metabolism: an in vivo microdialysis study comparing normal and 6– hydroxydopamine-lesioned rats. Brain Res., v630:57– 64.
   Google Scholar
• de Nucci, G., Gryglewski, R.J., Warner, T.D., and Vane, J.R. (1988). Receptor-mediated release of endothelium- derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc. Natl. Acad. Sci. U.S.A., 85:2334–2338.
   PubMed Web of Science ®Google Scholar
• Delesque, N., Buscail, L., Esteve, J.P., Rauly, I., Zeggari, M., Saint-Laurent, N., Bell, G.I., Schally, A.V., Vayasse, N., and Susini, C. (1995). Somatostatin and its receptors. Ciba Foundation Symposia, (London, D.J., Chadwick, D.J., and Cardew, G., Eds.). Wiley and Sons, Chichester, 190:187–203.
   Google Scholar
• Deuel, T.F., Senior, R.M., Huang, J.S., and Griffin, G.L. (1982). Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J. Clin. Invest., 69:1046–1049.
   PubMed Web of Science ®Google Scholar
• Donabedian, H. and Gallin, J.I. (1981). Deactivation of hu- man neutrophil chemotaxis by chemoattractants: ef- fects on receptors for the chemotactic factor f-Met- Leu-Phe. J. Immunol., 127:839–844.
   PubMed Web of Science ®Google Scholar
• D’Orleans-Juste, P., de Nucci, G., and Vane, J.R. (1989). Kinins act on B1 or B2 receptors to release conjointly endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells. Br. J. Pharmacol., 96:920–926.
   PubMed Web of Science ®Google Scholar
• Dubois, M., Pickar, D., Cohen, M.R., Roth,Y.F., McNamara, T., and Bunney, W.E. (1981). Surgical stress in hu- mans is accompanied by an increase in plasma beta- endorphin immunoreactivity. Life Sci., 29:1249–1254.
   PubMed Web of Science ®Google Scholar
• Elferink, J.G.R. and de Koster, B.M. (1996). The effects of endothelin-2 (ET-2) on migration and changes in cy- tosolic free calcium of neutrophils. Naunyn-Schm. Arch. Pharmacol., 353:130–135.
   Google Scholar
• Erickson, G.F., Li, D., Sadrkhanloo, R., Liu, X-J., Shimasaki, S., and Ling, N. (1994). Extrapituitary actions of go- nadotropin-releasing hormone: Stimulation of insu- lin-like growth factor-binding protein-4 and atresia. Endocrinology, 134:1365–1372.
   PubMed Web of Science ®Google Scholar
• Faith, R.E., Liang, H.J., Murgo, A.J., and Plotnikoff, N.P. (1984). Neuroimmunomodulation with enkephalins: Enhancement of human natural killer (NK) cell activ- ity in vitro. Clin. Immunol. Immunopathol., 31:412– 418.
   Google Scholar
• Fang, F.G., Moreau, J.L., and Fields, H.L. (1987). Dose dependent antinociceptive action of neurotensin mi- croinjected into the rostroventromedial medulla of the rat. Brain Res., 420:171–174.
   PubMed Web of Science ®Google Scholar
• Fannon, M. and Nugent, M.A. (1996). Basic fibroblast growth factor binds its receptors, is internalized, and stimu- lates DNA synthesis in BALB/c3T3 cells in the ab- sence of heparin sulfate. J. Biol. Chem., 271:17949– 17956.
   Web of Science ®Google Scholar
• Fernandez, H.N., Henson, P.M., Otani, A., and Hugli, T.E. (1978). Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo con- ditions. J. Immunol., 120:109–115.
   PubMed Web of Science ®Google Scholar
• Fletcher, M.P. and Gallin, J.I. (1980). Degranulating stimuli increase the availability of receptors on human neu- trophil for the chemoattract f-met-leu-phe. J. Immunol., 124:1585–1588.
   PubMed Web of Science ®Google Scholar
• Fletcher, M.P., Seligmann, B.E., and Gallin, J.I. (1982). Cor- relation of human neutrophil secretion, chemoattractant receptor mobilization and enhanced functional capac- ity. J. Immunol., 128:941–948.
   PubMed Web of Science ®Google Scholar
• Flood, J.F., Hernandez, E.N., and Morley, J.E. (1987). Modu- lation of memory processing by neuropeptide Y. Brain Res., 421:280–290.
   PubMed Web of Science ®Google Scholar
• Foekens, J.A., Sieuwerts, A.M., Stuurman-Smeet, E.M.J., Dorssers, L.C.J., Bern, E.M.J.J., and Klun, J.G.M. (1992). Pleiotropic actions of suramin on the prolif- eration of human breast-cancer cells in vitro. Int. J. Cancer, 51:439–444.
   PubMed Web of Science ®Google Scholar
• Folkman, J. and Klagsbrun, M. (1987). Angiogenic factors. Science, 235:442–447.
   PubMed Web of Science ®Google Scholar
• Fong, C-J., Sutkowski, D.M., Braun, E.J., Bauer, K.D., Sherwood, E.R., Lee, C., and Kozlowski, J.M. (1993). Effect of retinoic acid on the proliferation and secre- tory activity of androgen-responsive prostatic carci- noma cells. J. Urology, 149:1190–1194.
   PubMed Web of Science ®Google Scholar
• Frager, M.S., Pieper, D.R., Tonetta, S.A., Duncan, J.A., and Marshall, J.C. (1981). Pituitary gonadotropin-releas- ing hormone receptors. Effects of castration, steroid replacement, and the role of gonadotropin-releasing hormone in modulating receptors in the rat. J. Clin. Invest., 67:615–623.
   PubMed Web of Science ®Google Scholar
• Fraioli, F., Moretti, C., Paolucci, D., Alicicco, E., Crescenzi, F., and Fortunio, G. (1980). Physical exercise stimu- lates marked concomitant release of β-endorphin and adrenocorticotropic hormone (ACTH) in peripheral blood in man. Experientia, 36:987–989.
   PubMedGoogle Scholar
• Fruchtman, S., Jackson, L., and Borski, R. (2000). Insulin- like growth factor I disparately regulates prolactin and growth hormone synthesis and secretion: studies us- ing the teleost pituitary. Endocrinology, 141:2886– 2894.
   Web of Science ®Google Scholar
• Gabrilovac, J., Antica, M., and Osmak, M. (1991). In vivo bidirectional regulation of mouse natural killer (NK) cell cytotoxic activities by Leu-enkephalin: reversibility by naloxone. Life Sci., 50:29–37.
   Web of Science ®Google Scholar
• Gee, A.P., Boyle, M.D.P., Munger, K.L., Lawman, M.J.P., and Young, M. (1983). Nerve growth factor: Stimula- tion of polymorphonuclear leukocyte chemotaxis in vitro. Proc. Natl. Acad. Sci. U.S.A., 80:7215–7218.
   PubMed Web of Science ®Google Scholar
• George, S.T., Berrios, M., Haddcock, J.R., Wang, H.Y., and Malbon, C.C. (1988). Receptor and cAMP accumula- tion: analysis in CHO cells exhibiting stable expres- sion of a cDNA that encodes the beta2 adrenergic receptor. Biochem. Biophys. Res. Commun., 150:665– 672.
   Web of Science ®Google Scholar
• Gilman, S.C., Schwartz, J.M., Milner, R.J., Bloom, F.E., and Feldman, J.D. (1982). β-endorphin enhances lympho- cyte proliferation responses. Proc. Natl. Acad. Sci. USA, 79:4226–4230.
   PubMed Web of Science ®Google Scholar
• Goetzl, E.J. (1975). Modulation of human neutrophil poly- morphonuclear leucocyte migration by human plasma alpha-globulin inhibitors and synthetic esterase in- hibitors. Immunology, 29:163–174.
   PubMed Web of Science ®Google Scholar
• Gospodarowicz, D., Neufield, G., and Schweigerer, L. (1987). Fibroblast growth factor: Structural and biological properties. J. Cell Physiol., 5:15–26.
   Google Scholar
• Granstrom, B., Adner, M., Uddman, R., Edvinsson, L., and Cardell, L.O. (1997). Characterization of endothelin induced relaxation in guinea-pig airways: evidence for dilatory ETA- and ETB-receptors. Pul. Pharmacol. Therap., 10:293–298.
   PubMed Web of Science ®Google Scholar
• Griesbacher, T., Sametz, W., Legat, F.J., Diethart, S., Ham- mer, S., and Juan, H. (1997). Effects of the non- peptide B2 antagonist FR 17365:7 on kinin-induced smooth muscle contraction and relaxation, vasocon- striction and prostaglandin release. Br. J. Pharmacol., 121:469–476.
   PubMed Web of Science ®Google Scholar
• Guo, X.-J., Fantini, J., Roubin, R., Marvaldi, J., and Rougon, G. (1990). Evaluation of the effect of suramin on neural cell growth and N-CAM expression. Cancer Res., 50:5164–5170.
   PubMed Web of Science ®Google Scholar
• Haakansson, L. and Venge, P. (1983). Partial characteriza- tion and identification of chemokinetic factors in se- rum. Scand. J. Immunol., 18:531–537.
   PubMed Web of Science ®Google Scholar
• Han, A.S., Maeda, Y., and Knepper, M.A. (1993). Dual actions of vasopressin and oxytocin in regulation of water permeability in terminal collecting duct. Am. J. Physiol., 265:F26–F34.
   Google Scholar
• Harris, P.J. and Navar, L.G. (1985). Tubular transport re- sponses to angiotensin. Am. J. Physiol., 248:F621– F630.
   PubMed Web of Science ®Google Scholar
• Harris, P.J. and Young, J.A. (1977). Dose-dependent stimu- lation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney. Pfluegers Arch., 367:295–297.
   Google Scholar
• Hart, I.R., Talmage, J.E., and Fidler, I.J. (1981). Metastatic behavior of a murine reticulum cell sarcoma exhibit- ing organ specific growth. Cancer Res., 41:1281– 1287.
   Web of Science ®Google Scholar
• Havlicek, V., Rezek, M., and Friesen, H. (1976). Somatosta- tin and thyrotropin releasing hormone: Central effect on sleep and motor system. Pharmacol. Biochem. Behav., 4:455–459.
   PubMed Web of Science ®Google Scholar
• Hawker, J.R.J. and Granger, H.J. (1994) Nuclear accumula- tion of exogenous basic fibroblast growth factor in endothelial, fibroblast, and myoblast cell lines results in diverse biological responses. In Vitro Cell Dev. Biol. 30A:653–663.
   Web of Science ®Google Scholar
• Hazum, E., Chang, K-J., and Cuatrecasas, P. (1979). Spe- cific nonopiate receptors for β-endorphin. Science, 205:1033–1035.
   PubMed Web of Science ®Google Scholar
• Hedge, S.S. and Clarke, D.E. (1993). Characterization of angiotensin receptors mediating the neuromodulatory effects of angiotensin in the vas deferens of the rabbit. J. Pharmacol. Exper. Therap., 265: 601–608.Heisler, S. (1976). Calcium and cyclic nucleotide involvement in exocrine pancreatic enzyme secretion studied with the ionophore A23187. Life Sci., 19:233–242.
   Google Scholar
• Heisler, S. and Srikant, C.B. (1985). Somatostatin-14 and soma- tostatin-28 pretreatment down-regulate somatostatin-14 receptors and have biphasic effects on forskolin-stimu- lated cyclic adenosine, 3’.5’-monophosphate synthesis and adrenocorticotropin secretion in mouse anterior pi- tuitary tumor cells. Endocrinology, 117:217–225.
   PubMed Web of Science ®Google Scholar
• Heldin, C.H., Wasteson, A., and Westermark, B. (1982). Interaction of platelet-derived growth factor with its fibroblast receptor. Demonstration of ligand degrada- tion and receptor modulation. J. Biol. Chem., 257:4216–4221.
   PubMed Web of Science ®Google Scholar
• Hellman, B. and Lernmark, A. (1969). Inhibition of the in vitro secretion of insulin by an extract of pancreatic a1 cells. Endocrinology, 84:1484–1487.
   PubMed Web of Science ®Google Scholar
• Heron, D.S., Shinitzky, M., Hershkowitz, M., and Samuel, D. (1980). Lipid fluidity markedly modulates the bind- ing of serotonin to mouse brain membranes. Proc. Natl. Acad. Sci., U.S.A. 77:7463–7467.
   PubMed Web of Science ®Google Scholar
• Heymann, M.A., Rudolph, A.M., and Silverman, N.H. (1976). Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N. Engl. J. Med., 295:530–533.
   PubMed Web of Science ®Google Scholar
• Hofland, L.J., van Koetsveld, P.M., Waaljers, M., Zuyderwijk, J., Breeman, W.A.P., and Laberts, S.W.J. (1995). In- ternalization of the radioiodinated somatostatin ana- log {125 I-Tyr3} octreotide by mouse and human pitu- itary tumor cells: increase by unlabeled octreotide. Endocrinlogy, 136:3698–3706.
   PubMed Web of Science ®Google Scholar
• Huang, J.S., Huang, S.S., Kennedy, B., and Deuel, T.F. (1982). Platelet-derived growth factor: specific bind- ing to target cells. J. Biol. Chem., 257:8130–8136.
   PubMed Web of Science ®Google Scholar
• Hugli, T.E. (1979). In: The Chemistry and Physiology of the Human Plasma Proteins, (D.H. Bing, Ed.) Pergamon, New York, pp. 255–280.
   Google Scholar
• Hurnanen, D., Chan, H.M., and Kubow, S. (1997). The protective effect of metallothionein against lipid peroxidation caused by retinoic acid in human breast cancer cells. J. Pharmacol. Exper. Therap., 283:1520– 1528.
   Web of Science ®Google Scholar
• Kaiser, U.B., Jakubowiak, A., Steinberger, A., and Chin, W.W. (1993). Regulation of rat pituitary gonadotro- pin-releasing hormone receptor mRNA levels in vivo and in vitro. <i>Endocrinology, 133:931–934.
   Google Scholar
• Kalivas, P.W., Jennes, L., Nemeroff, C.B., and Prange, A.J. (1982). Neurotensin: Topographical distribution of brain sites involved in hypothermia and antinociception. J. Comp. Neurol., 210:225–238.
   PubMed Web of Science ®Google Scholar
• Kaltschmidt, B., Uherek, M., Wellmann, H., Volk, B., and Kaltschmidt, C. (1999). Inhibition of NF-kB potenti- ates amyloid β-mediated neuronal apoptosis. Proc. Natl. Acad. Sci. USA, 96:9409–9414.
   PubMed Web of Science ®Google Scholar
• Katt, J.A., Duncan, J.A., Herbon, L., Barkan, A., and Marshall, J.C. (1985). The frequency of gonadotropin-releasing hormone stimulation determines the number of pitu- itary gonadotropin-releasing hormone receptors. En- docrinology, 116:2113–2115.
   PubMed Web of Science ®Google Scholar
• Kay, N., Allen, J., and Morley, J.E. (1984). Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity. Life Sci., 35:53–59.
   PubMed Web of Science ®Google Scholar
• Kay, N., Morley, J.E., and van Ree, J.M. (1987). Enhance- ment of human lymphocyte natural killing function by non-opioid fragments of β-endorphin. Life Sci., 40:1083–1087.
   PubMed Web of Science ®Google Scholar
• Khan, S., Whelpton, R., and Michael-Titus, A.T. (2000). Substance P modulation of striatal dopamine outflow is determined by M1 and M2 muscarinic receptors in male Wistar rats. Neurosci. Lett., 293:179–182.
   PubMed Web of Science ®Google Scholar
• Kimura, A., Katoh, O., Hyodo, H., and Kuramoto, A. (1989). Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. Br. J. Haematol., 72:486–491.
   PubMed Web of Science ®Google Scholar
• Kineman, R.D., Getty, T.W., and Frawley, L.S. (1994). Para- doxical effects of dopamine (DA): Gi3 mediates DA inhibition of PRL release while masking its PRL- releasing activity. Endocrinology, 135:790–793.
   PubMed Web of Science ®Google Scholar
• Klijn, J.G.M., Setyono-Han, B., Bakker, G.H., van der Burg, M.E.L., Bontenbal, M., Peters, H.A., Sieuwerts, A.M., Berns, P.M.J.J., and Foekens, J.A. (1990). Growth factor-receptor pathway interfering treatment by so- matostatin analogs and suramin: preclinical and clini- cal studies. J. Steroid Biochem., 37:1089–1095.
   Google Scholar
• Korc, M., Bailey, A.C., and Williams, J.A. (1981). Regula- tion of protein synthesis in normal and diabetic rat pancreas by cholecystokinin. Am. J. Physiol., 241:G116–G121.
   Google Scholar
• Krsmanovic, L.Z., Arora, K.K., Stojikovic, S.S., and Catt, K.J. (1994). Autocrine regulation of gonadotropin- releasing hormone (GnRH) secretion via GnRH re- ceptor expressed in cultured hypothalamic cells. 76th Annual Meeting of the Endocrine Society, Anaheim, CA, p. 520 (Abstract).
   Google Scholar
• Krsmanovic, L.Z., Stojilkovic, S.S., Mertz, A.M., Tomic, M., and Catt, K.J. (1993). Expression of gonadotro- pin-releasing hormone receptors and autocrine regulation of neuropeptide release in immortalized hypo- thalamic neurons. Proc. Natl. Acad. Sci. USA, 90:3908–3912.
   PubMed Web of Science ®Google Scholar
• Krulich, L., Dhariwal, A.P.S., and McCann, S.M. (1968). Stimulatory and inhibitory effects of purified hypo- thalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology, 83:783–790.
   PubMed Web of Science ®Google Scholar
• Kurosaka, H., Kurosaka, D., Kato, K., Mashima, Y., and Tanaka, Y. (1998). Transforming growth factor-β1 pro- motes contraction of collagen gel by bovine corneal fibroblasts through differentiation of myofibroblasts. Invest. Ophthalmol. Visual Sci., 39:699–704.
   PubMed Web of Science ®Google Scholar
• Lara, J.I., Lorenzo, M. J., Cacicedo, L., Tolon, R. M., Balsa, J.A., Loopez-Fernandez, J., and Sanchez-Franco, F. (1994). Induction of vasoactive intestinal peptide gene expression and prolactin secretion by insulin-like growth factor I in rat pituitary cells: evidence for an autoparacrine regulatory system. Endocrinology, 135:2526–2532.
   PubMed Web of Science ®Google Scholar
• Lauffer, J. M., Modlin, I. M., Kidd, M., Zhang, T., Kog, T., and Tang, L. (1998). Pituitary adenylate cyclase-acti- vating peptide modulates gastric ECL cell prolifera- tion in rats. Gastroenterology, 114 (Suppl.), abstract 138.
   Google Scholar
• Lee, E.H.Y., Ma, Y.L., Wayner, M., and Armstrong, D.L. (1995). Impaired retention by angiotensin II mediated by the AT1 receptor. Peptides, 16:1069–1071.
   PubMed Web of Science ®Google Scholar
• Lelievre, V., Pineau, N., Du., J., Wen, C.H, Nguyen, T., Janet, T., Muller, J.M., and Waschek, J.A. (1998). Differential effects of peptide histidine isoleucine (PHI) and related peptides on stimulation and suppression of neuroblastoma cell proliferation. J. Biol. Chem., 273:19685–19690.
   PubMed Web of Science ®Google Scholar
• Leof, E.B., Proper, J.K., Goustin, A.S., Shipley, G.D., DiCorleto, P.E., and Moses, H.L. (1986). Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. Proc. Natl. Acad. Sci. U.S.A., 83:2453–2457.
   PubMed Web of Science ®Google Scholar
• Levens, N.R. (1983). Response of rat jejunum to angio- tensin. III. Pharmacology and mechanism of action. Am. J. Physiol., 245:G511–G518.
   Google Scholar
• Liao, C.S. and Freer, R.J. (1980). Cryptic receptors for chemotatic peptides in rabbit neutrophils. Biochem. Biophys. Res. Commun., 93:566–571.
   PubMed Web of Science ®Google Scholar
• Lopker, A., Abood, L.G., Haas, W., and Lionetti, F.J. (1980). Stereoselective muscarinic acetylcholine and opiate receptors in human phagocytoic leukocytes. Biochem. Pharmacol., 29:1361–1365.
   PubMed Web of Science ®Google Scholar
• Lorenzo, M.J., Cacicedo, C., Tolon, R.M., Balsa, J.A., and Sanchez-Franco, F. (1995). Triiodothyronine regu- lates somatostatin gene expression in cultured fetal rat cerebrocortical cells. Peptides, 16:249–253.
   PubMed Web of Science ®Google Scholar
• Loumaye, E. and Catt, K.J. (1982). Homologous regulation of gonadotropin-releasing hormone receptors in cul- tured pituitary cells. Science, 215:983–985.
   PubMed Web of Science ®Google Scholar
• Lowitz, H.D., Stumpe, K.O., and Ochwadt, B. (1969). Mi- cropuncture study of the action of angiotensin-II on tubular sodium and water reabsorption in the rat. Nephron, 6:173–187.
   PubMed Web of Science ®Google Scholar
• Luo, Q., Peyman, G.A., Conway, M.D., and Woltering, E.A. (1996). Effect of a somatostatin analog (octreotide acetate) on the growth of retinal pigment epithelial cells in culture. Current Eye Res., 15: 909–913.
   PubMed Web of Science ®Google Scholar
• Luscinkas, F.W., Kiely, J.-M., Ding, H., Obin, M.S., Hebert, C.A., Baker, J.M., and Gimbrone, M.A., Jr. (1992). In vitro inhibitory effect of IL-8 and other chemoattractants on neutrophil endothelial adhesive interactions. J. Immunol., 149:2163–2171.
   PubMed Web of Science ®Google Scholar
• Mahr, S., Neumayer, N., Kolb, H.J., Schepp, W., Classen, M., and Prinz, C. (1998). Growth factor effects on apoptosis of rat gastric enterochromaffin-like cells. Endocrinology, 139:4380–4390.
   PubMed Web of Science ®Google Scholar
• Marian, J., Cooper, R.L., and Conn, P.M. (1981). Regulation of the rat pituitary gonadotropin-releasing hormone receptor. Mol. Pharmacol., 19:399–405.
   PubMed Web of Science ®Google Scholar
• McAfee, R.D. and Locke, W. (1967). Effect of angiotensin amide on sodium isotope flux and short-circuit cur- rent of isolated frog skin. Endocrinology, 81:1301– 1305.
   Web of Science ®Google Scholar
• McAnulty, R.J., Chambers, R.C., and Laurent, G.J. (1995). Regulation of fibroblast procollagen production. Trans- forming growth factor-beta 1 induces prostaglandin E2 but not procollagen synthesis via a pertussis toxin- sensitive G-protein. Biochem. J., 307:63–68.
   PubMed Web of Science ®Google Scholar
• McAnulty, R.J., Hernandez-Rodriguez, N.A., Mutsaers, S.E., Coker, R.K., and Laurent, G.J. (1997). Indomethacin suppresses the antiproliferative effects of transform- ing growth factor-β isoforms on fibroblast cell cul- tures. Biochem. J., 321:639–643.
   PubMed Web of Science ®Google Scholar
• McCain, H.W., Bilotta, J., and Lamster, I.B. (1987). Endorphinergic modulation of immune function: Po- tent action of the dipeptide clycyl-l-glutamine. Life Sci., 41:169–176.
   PubMed Web of Science ®Google Scholar
• Miller, W.L., Wu, J.C., and Sealfon, S.C. (1993). Estradiol progesterone inhibin, GnHR regulate GnRH receptor mRNA(s) in ovine pituitary cultures. 75th Annual Meeting of the Endocrine Society, Las Vegas, NV, p. 61 (Abstract).
   Google Scholar
• Mitchell, M.D., Lucas, A., Etches, P.C., Brunt, J.D., and Turnbull, A.C. (1978). Plasma prostaglandin levels during early neonatal life following term and preterm delivery. Prostaglandins, 16:319–326.
   PubMedGoogle Scholar
• Morrison, H.M., Kramps, J.A., Burnett, D., and Stockley, R.A. (1987). Lung lavage fluid from patients with a1– proteinase inhibitor deficiency or chronic obstructive bronchitis. Clin. Sci., 72:373–381.
   PubMed Web of Science ®Google Scholar
• Muller, C.P. and Shinitzky, M. (1979). Modulation of trans- ferrin receptors in bone marrow cells by changes in lipid fluidity. Br. J. Hematol., 42:355–362.
   PubMed Web of Science ®Google Scholar
• Muller, J.M., Lelievre, V., Becq-Giraudon, L., and Meunier, A.C. (1995). VIP as a cell-growth and differentiation neuromodulator role in neurodevelopment. Mol. Neurobiol., 10:115–134.
   PubMed Web of Science ®Google Scholar
• Munday, K.A., Parsons, B.J., and Poat, J.A. (1971). The effect of angiotensin on cation transport by rat kidney cortex slices. J. Physiol. London, 215:269–282.
   Google Scholar
• Murono, E.P., Goforth, D.P., Washburn, A.L., and Wu, N. (1993). Evidence that biphasic effects of fibroblast growth factor on 5–ene-3B-hydroxysteroid dehydro-genase-isomerase activity in cultured immature Leydig cells are mediated by binding to heparan sulfate proteoglycans. J. Steroid Biochem. Mol. Biol., 46:557– 563.
   Web of Science ®Google Scholar
• Nakao, K., Nakai, Y., Oki, S., Horii, K., and Imura, H. (1978). Presence of immunoreactive β-endorphin in normal human plasma. J. Clin. Invest., 62: 1395–1398.Nemecek, G., St. Denny, I., Van Valen, R.G., and McCarthy, L.A. (1989). Terbinafine inhibits the mitogenic re- sponse to platelet-derived growth factor in vitro and neointimal proliferation in vivo. J. Pharmacol. <i>Exper. Therap., 248:1167–1174.
   Google Scholar
• Neufield, G., Ferrara, N., Schweigerer, L., Mitchell, R., and Gospodarowicz, D. (1987). Bovine granulosa cells produce basic fibroblast growth factor. Endocrinol- ogy, 121:597–603.
   PubMed Web of Science ®Google Scholar
• Niedel, J.E. and Cuatrecasas, P. (1980). Formyl peptide chemotactic receptors of leukocytes and macrophases. Curr. Top. Cell Regul., 17:137–170.
   PubMedGoogle Scholar
• Nio, D.A., Moylan, R.N., and Roche, J.M. (1993). Modula- tion of T lymphocyte function by neuropeptides. J. Immunol., 150:5281–5288.
   PubMedGoogle Scholar
• Oleson, D.R. and Johnson, D.R. (1988). Regulation of hu- man natural cytotoxicity by enkephalins and selective opiate agonists. Brain Behav. Immunol., 2: 171–186.Oliver, M., Harrison, N.K., Bishop, J.E., Cole, P.J., and Laurent, G.J. (1989). A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J. Cell Sci., 92:513–518.
   Google Scholar
• Olivier, S., Formento, P., Fischel. P., Etienne, M.C., and Milano, G. (1990). Epidermal growth factor receptor expression and suramin cytotoxicity in vitro. Eur. J. Cancer, 26:867–871.
   Web of Science ®Google Scholar
• Olley, P.M., Coceani, F., and Bodach, E. (1976). E-type prostaglandins. A new emergency therapy for certain cyanotic congenital heart malformations. Circulation, 53:728–731.
   PubMed Web of Science ®Google Scholar
• Papachristou, D.N., Liu, J-L., and Patel, Y.C. (1994). Gluco- corticoids regulate somatostatin peptide and steady state messenger ribonucleic acid levels in normal rat tissues and in a somatostatin-producing islet tumor cell line (l027B2). Endocrinology, 134:2259:2266.
   Web of Science ®Google Scholar
• Peng, C., Fan, N.C., Ligier, M., Vaananen, J., and Leung, P.C.K. (1994). Expression and regulation of gonadot- ropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells. Endocrinology 135:1740–1746.
   PubMed Web of Science ®Google Scholar
• Peterfreund, R.A., Sawchenko, P.E., and Vale, W. (1985). Thyroid hormones reversibly suppress somatostatin secretion and immunoactivity in cultured neocortical cells. Brain Res., 328:259–270.
   PubMed Web of Science ®Google Scholar
• Porterfield, S.P. and Hendrich, C.E. (1993). The role of thyroid hormones in prenatal and neonatal neurologi- cal development current perspectives. Endocr. Rev., 4:94–106.
   Google Scholar
• Prevost, G., Foehrle, E., Thomas, F., Pihan, I., Veber, N., Starzec, A., and Israel, L. (1991). Growth of human breast cancer cell lines is inhibited by the somatostatin analog BIM23014. Endocrinology, 129:323–329.
   PubMed Web of Science ®Google Scholar
• Prinz, C., Scott, D. R., Durwitz, D., Helander, H. F., and Sachs, G. (1994). Gastrin effects on isolated rat en- terochromaffin-like cells in primary culture. Am. J. Physiol., 267:G663–G675.
   PubMedGoogle Scholar
• Ramirez, J.L., Torronteras, R., Castano, J.P., Sanchez- Hormigo, A., Garrido, J.C., Garcia-Navarro, S., and Gracia-Navarro, F. (1997). Somatostatin plays a dual, stimulatory/inhibitory role in the control of growth hormone secretion by two somatotrope subpopula- tions from porcine pituitary. J. Neuroendocr., 9:841– 848.
   Web of Science ®Google Scholar
• Ramirez, J.L., Castano, J.P., and Gracia-Navarro, F. (1998). Somatostatin at low doses stimulates growth hormone release from intact cultures of porcine pituitary cells. Horm. Metab. Res., 30:175–177.
   PubMed Web of Science ®Google Scholar
• Raynor, K., Lucki, I., and Reisine, T. (1993). Somatostatin1 receptors in the nucleus accumbens selectively medi- ate the stimulatory effect of somatostatin on locomo- tor activity in rats. J. Pharmacol. Exper. Therap., 265:67–73.
   PubMed Web of Science ®Google Scholar
• Regoli, D., Rhaleb, N.E., Drapeau, G., and Dion, S. (1990). Kinin receptor subtypes. J. Cardiovasc. Pharmacol., 15(Suppl 6):S30–S38.
   Web of Science ®Google Scholar
• Reichlin, S. (1983). Somatostatin. N Engl. J. Med., 309:1495– 1501.
   Google Scholar
• Rezek, M., Havlicek, V., Hughes, K.R., and Friesen, H. (1976). Cortical administration of somatostatin (SRIF): effect on sleep and motor behavior. Pharmacol. Biochem. Behav., 5:73–77.
   PubMed Web of Science ®Google Scholar
• Rezek, M., Havlicek, V., Hughes, K.R., and Friesen, H. (1977). Behavioural and motor excitation and inhibi- tion induced by the administration of small and large doses of somatostatin into the amygdala. Neurophar- macology, 16:157–162.
   PubMed Web of Science ®Google Scholar
• Ross, R., Raines, E.W., and Bowen-Pope, D. F. (1986). The biology of platelet-derived growth factor. Cell, 46:155– 169.
   Web of Science ®Google Scholar
• Rubanyi, G.M. and Polokoff, M.A. (1994). Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev., 46:325–415.
   PubMed Web of Science ®Google Scholar
• Ruff, M., Schiffman, E., Terranova, V., and Pert, C.B. (1985). Neuropeptides are chemoattractants for human tumor cells and monocytes. A possible mechanism for me- tastasis. Clin. Immunol. Immunopathol., 37:387–396.
   PubMedGoogle Scholar
• Russo, R.G., Liotta, L.A., Thorgeirsson, U., Brundage, R., and Schiffman, E. (1981). Polymorphonuclear leuko- cyte migration through human amnion membrane. J. Cell. Biol., 91:459–467.
   PubMed Web of Science ®Google Scholar
• Ryder, N.S. (1985).Specific inhibition of fungal sterol bio- synthesis by SF 86–327, a new allylamine antimy- cotic agent. Antimicrob. Agents Chemother., 27:252– 256.
   Google Scholar
• Ryder, N. S. (1987). Squalene epoxidase as the target of antifungal allylamines. Pesticide Sci., 21:281–288.
   Google Scholar
• Ryder, N.S. and Dupont, M.C. (1985). Inhibition of squalene epoxidase by allylamine antimycotic compounds. Biochem. J., 230:765–770.
   PubMed Web of Science ®Google Scholar
• Savoy-Moore, R.T., Schwartz, N.B., Duncan, J.A., and Marshall, J.C. (1980). Pituitary gonadotropin-releasing hormone receptors during the rat estrous cycle. Science, 209:942–944.
   PubMed Web of Science ®Google Scholar
• Schuster, V.L., Kokko, J.P., and Jacobson, H.R. (1984). Angiotensin II directly stimulates sodium transport in rabbit proximal convoluted tubules. J. Clin. Invest., 73:507–515.
   PubMed Web of Science ®Google Scholar
• Senior, R.M., Griffin, G.L., and Mecham, R.P. (1982). Chemotactic responses of fibroblasts to tropoelastin and elastin-derived peptides. J. Clin. Invest., 70:614– 618.
   Web of Science ®Google Scholar
• Senior, R.M., Griffin, G.L., Huang, J., Walz, D.A., and Devel, T. (1983). Chemotactic activity of platelet al- pha granule proteins for fibroblasts. J. Cell Biol., 96:382–385.
   PubMed Web of Science ®Google Scholar
• Senior, R.M., Huang, J.S., Griffin, G.L., and Deuel, T.F. (1985). Association of the chemotactic and mitogenic activities of platelet-derived growth factor in human neutrophil elastase. J. Cell Biol., 100:351–356.
   PubMed Web of Science ®Google Scholar
• Setyono-Han, B., Henkelman, M.S., Foekens, J.A., and Klijn, J.G.M. (1987). Direct inhibitory effects of somatosta- tin (analogues) on the growth of human breast cancer cells. Cancer Res., 47:1566–1570.
   PubMed Web of Science ®Google Scholar
• Shahabi, N.A., Heagy, W., and Sharp, B.M. (1996). β-endor- phin enhances concanavalin-A-stimulated calcium mobilization by murine splenic T cells. Endorcinology, 137:3386–3393.
   PubMed Web of Science ®Google Scholar
• Shinitzky, M. (1979). In: Physical and Chemical Aspects of Cell Surface Events in Cellular Regulations (C. DeLisi, and R. Blumethal, Eds.) Elsevier/North-Holland, New York, pp. 173–181.
   Google Scholar
• Simonson, M.S. (1993). Endothelins: multifunctional renal peptides. Physiol. Rev., 73:375–411.
   PubMed Web of Science ®Google Scholar
• Simpkins, C.O., Dickey, C.A., and Fink, M.P. (1984). Hu- man neutrophil migration is enhanced by beta-endor- phin. Life Sci., 34:2251–2255.
   PubMed Web of Science ®Google Scholar
• Smith, D.J., Hawranko, A.A., Monroe, P.J., Gully, D., Ur- ban, M.O., Craig, C.R., Smith, J.P., and Smith, D.L. (1997). Dose-dependent pain-facilitatory and -inhibi- tory actions of neurotensin are revealed by SR 48692, a nonpeptide neurotensin antagonist: Influence on the antinociceptive effect of morphine. J. Pharmacol. Exper. Therap., 282:899–908.
   PubMed Web of Science ®Google Scholar
• Soma, Y. and Grotendorst, G.R. (1989). TGF-β stimulates primary human skin fibroblast DNA synthesis via autocrine production of PDGF-related peptides. J. Cell. Physiol., 140:246–253.
   PubMed Web of Science ®Google Scholar
• Spinelli, F. and Walther, A. (1979). Modulation by prostag- landins of angiotensin II-induced stimulation of so- dium transport in the proximal tubule of rat. Colloq. INSERM, 85:273–278.
   Google Scholar
• Stockley, R. A., Shaw, J., Afford, S. C., Morrison, H. M., and Burnett, D. (1990). Effect of alpha-1–proteinase inhibitor on neutrophil chemotaxis. Am. J. Respir. Cell Mol. Biol., 2:163–170.
   PubMed Web of Science ®Google Scholar
• Szalay, Sz. K. and Stark, E. (1981). Effect of beta-endorphin on the steroid production of isolated zona glomerulosa and zona fasciculata cells. Life Sci., 29:1355–1561.
   PubMed Web of Science ®Google Scholar
• Talmage, J.E., Kay, M.E., and Hart, I.R. (1981). Character- ization of a murine ovarian reticulum cell sarcoma of histiocytic origin. Cancer Res., 41:1271–1280.
   PubMedGoogle Scholar
• Tang, L.H., Modlin, I.M., Lawton, G.P., Kidd, M., and Chinery, R. (1996). The role of transforming growth factor in the enterochromaffin-like cell tumor au- tonomy in an African rodent. Gasroenterology, 111:1212–1223.
   PubMed Web of Science ®Google Scholar
• Taniguchi, T., Nakai, Y., Karim, Z., Gu, Z-B., Kawase, K., and Kitazawa, Y. (1999). Biphasic intraocular pres- sure response to calcitonin gene-related peptide. Cur- rent Eye Res., 19:432–438.
   PubMed Web of Science ®Google Scholar
• Ten Dijke, P., Iwata, K.K., Goddard, C., Pieler, C., Canalis, E., McCarthy, T.L., and Centrella, M. (1990). Recom- binant transforming growth factor type beta 3: bio- logical activities and receptor-binding properties in isolated bone cells. Mol. Cell. Biol., 10:4473–4479.
   PubMed Web of Science ®Google Scholar
• Thibonnier, M., Preston, J.A., Dulin, N., Wilkins, P.L., Berti- Mattera, N., and Matterra, R. (1997). The human V3 pituitary vasopressin receptor: ligand binding profile and density-density-dependent signaling pathways. Endocrinology, 138:4109–4122.
   PubMed Web of Science ®Google Scholar
• Thorgeirsson, U.P., Liotta, L.A., Kalebic, T., Margulies, I.M., Thomas, K., Rios-Candelore, M., and Russo, R.G. (1982). Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro. J. Natl. Can. Inst., 69:1049–1054.
   Google Scholar
• Thurau, K., Schnermann, J., Nagel, W., Horster, M., and Wahl, M. (1967). Composition of tubular fluid in the macula densa segment as a factor regulating the func- tion of the juxtaglomerular apparatus. Circ. Res., 20/ 21 (Suppl. II):79–89.
   Google Scholar
• Tseng, C.J., Chou, L.L., Ger, L.P., and Tung, C.S. (1994). Cardiovascular effects of angiotension III in brainstem nuclei of normotensive and hypertensive rats. J. Pharm. Exper. Therap., 268:558–564.
   PubMed Web of Science ®Google Scholar
• Tsutsumi, M., Laws, S.C., and Sealfon, S.C. (1993). Ho- mologous up-regulation of the gonadotropin-releas- ing hormone receptor in -T3–1 cells is associated with unchanged receptor messenger RNA (mRNA) levels and altered mRNA activity. Mol. Endocrinol., 7:1625–1633.
   Google Scholar
• Tsutsumi, K., Kitagawa, N., Niwa, M., Yamaga, S., Khalid., H., Taniyama, K., Himeno, A., and Shibata, S. (1993). Biphasic effects of suramin on 125I-epidermal growth factor binding to human meningiomas. Cell. Mol. Neurobiol., 13:665–675.
   PubMed Web of Science ®Google Scholar
• Uemura, T., Yanagisawa, T., Shirasu, K., Matsuyama, A., Minaguchi, H. (1992). Mechanisms involved in the pituitary desensitization induced by gonadotropin-re- leasing hormone agonists. Am. J. Obstet. Gynecol., 167:283–291.
   PubMed Web of Science ®Google Scholar
• Ueno, N., Baird, A., Esch, F., Ling, N., and Guillemin, R. (1987). Isolation and partial characterization of basic fibroblast growth factor from bovine testis. Mol. Cell. Endocrinol., 49:189–194.
   PubMed Web of Science ®Google Scholar
• Urban, M.O. and Gebhart, C.F. (1997). Characterization of biphasic modulation of spinal nociceptive transmis- sion by neurotensin in the rat rostral ventromedial medulla. J. Neurophysiol., 78:1550–1562.
   PubMed Web of Science ®Google Scholar
• Urban, M.O. and Smith, D.J. (1993). Role of neurotensin in the nucleus raphe magnus in opioid-induced antinociception from the periaqueductal gray. J. Pharmacol. Exper. Therap., 265:580–586.
   Google Scholar
• Urban, M.O. and Smith, D.J. (1994). Localization of the antinociceptive and antianalgesic effects of neurotensin within the rostral ventromedial medulla. Neurosci. Lett., 174:21–25.
   PubMed Web of Science ®Google Scholar
• Urban, M.O., Jiang, M.C., and Gebhart, G.F. (1996). Partici- pation of central descending nociceptive facilitatory systems in secondary hyperalgesia produced by mus- tard oil. Brain Res., 737:83–91.
   PubMed Web of Science ®Google Scholar
• Urban, M.O., Smith, D.J., and Gebhart, G.F. (1996a). In- volvement of spinal cholecsytokininB receptors in mediating neurotensin hyperalgesia from the medul- lary nucleus raphe magnus in the rat. J. Pharmacol. Exp. Therap., 278:90–96.
   PubMed Web of Science ®Google Scholar
• Urban, M.O., Coutinho, S.V., and Gebhart, G.F. (1999). Biphasic modulation of visceral nociception by neurotensin in rat rostral ventromedial medulla. J. Pharmacol. Exp. Therap., 290:207–213.
   PubMed Web of Science ®Google Scholar
• van Epps, D.E., Saland, L., Taylor, C., and Williams, R.C. (1983). Immunology of nervous system infections, In: Progress in Brain Research (P.O. Behan, V. TerMeulen and F.C. Rose, Eds.) Elsevier Science Publications, New York, pp. 361–374.
   Google Scholar
• Vertongen, P., Camby, I., Darro, F., Kiss, R., and Robbericht, P. (1996). VIP and pituitary adenylate cyclase activat- ing polypeptide (PAPAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP2 receptor. Neuropep- tides, 30:491–495.
   PubMed Web of Science ®Google Scholar
• Vecsei, L., Bollok, I., and Telegdy, G. (1983). Comparative studies with cyclic and linear somatostatin on active avoidance behavior and open-field activity in rats. Acta. Physiol. Hung., 61:43–49.
   PubMedGoogle Scholar
• Vecsei, L., Kiraly, C., Bollok, I., Nagy, A., Varga, J., Penke, B., and Telegdy, G. (1984). Comparative studies with somatostatin and cysteamine in different behavioral tests on rats. Pharmacol. Biochem. Behav., 21:833– 837.
   Web of Science ®Google Scholar
• Wass, J.A., Varani, J., Piontek, G.E., Goff, D., and Ward, (1981). Characteristics of the chemotactic factor- mediated cell swelling response of tumor cells. J. Natl. Can. Inst., 66:927–933.
   PubMedGoogle Scholar
• Webster, P.D., Black, O., Mainz, D., and Singh, M. (1977). Pancreatic acinar cell metabolism and function. Gas- troenterology, 73:1434–449.
   PubMed Web of Science ®Google Scholar
• Whitebread, S., Mele, M., Kamber, B., and Gasparo, M. (1989). Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun., 163:284–291.
   PubMed Web of Science ®Google Scholar
• Williams, J.A. and Lee, M. (1974). Pancreatic acinar cells: Use of a Ca2+ ionophore to separate enzyme release from the earlier steps in stimulus-secretion coupling. Biochem. Biophys. Res. Commun., 60:542–548.
   PubMed Web of Science ®Google Scholar
• Williams, L.T., Tremble, P., and Antoniades, H.N. (1982). Platelet-derived growth factor binds specifically to receptor on vascular smooth muscle cells and the binding becomes nondissociable. PNAS, 79:5867– 5870.
   Web of Science ®Google Scholar
• Wybran, J., Appelborn, T., Famaey, J.P., and Govaerts, A. (1979). Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J. Immunol., 123:1068–1070.
   PubMed Web of Science ®Google Scholar
• Xu, M., Mizobe, F., Yamamoto, T., and Kato, T. (1989). Differential effect of M1 and M2 muscarinic drugs on striatal dopamine release and metabolism in freely moving rats. Brain Res., 495:232–242.
   PubMed Web of Science ®Google Scholar
• Yu, H., Carretero, O.A., Juncos, L.A., and Garvin, J.L. (1998). Biphasic effect of bradykinin on rabbit afferent arte- rioles. Hypertension, 32:287–292.
   PubMed Web of Science ®Google Scholar
• Yuli, I., Tomonaga, A., and Snyderman, R. (1982). Chemoattractant receptor functions in human polymorphonuclear leuko- cytes are divergently altered by membrane fluidizers. Proc. Natl. Acad. Sci. U.S.A., 79:5906–5910.
   PubMed Web of Science ®Google Scholar
• Zhang, C. and Mayeux, P.R. (2001). NO/cGMP signaling modulates regulation of Na+-K+-ATPase activity by angiotensin II in rat proximal tubules. Am. J. Physiol. Renal Physiol., 280:F474–F479.
   Web of Science ®Google Scholar
• Zhu, X., Gilbert, S., Birnbaumer, M., and Birnbaumer, L. (1994). Dual signaling potential is common among Gs-coupled receptors and dependent on receptor den- sity. Mol. Pharmacol., 46:460–469.
   PubMed Web of Science ®Google Scholar